Neuromuscular transmission motion sensor

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Available from:

GE Healthcare Australia Pty Ltd

Class:

Class IIa

Manufactured by:

GE Healthcare Finland Oy Kuortaneenkatu 2, Helsinki, FI-00510 Finland

Therapeutic area:

59692 - Neuromuscular transmission motion sensor

Therapeutic indications:

This is intended to be a non-sterile device intended to be placed on the thumb and index finger of a patient to detect movements and convert them into electrical neuromuscular transmission (NMT) signals during nerve stimulation. The device, also known as a mechanosensor, is a piezoelectric sensor that functions with an NMT sensor cable and skin surface NMT electrodes to transmit electrical signals to a patient monitoring module dedicated to the monitoring of patient relaxation to determine level of neuromuscular block. This is a reusable device

Authorization status:

A

Authorization date:

2017-04-18